Coming Soon

In the wake of the Supreme Court ruling last week that invalidated patents on isolated gene sequences held by Myriad Genetics, a number of companies are jumping in to offer BRCA1 and BRCA2 testing. Pharmacogenomics Reporter notes that Ambry Genetics, GeneDx, Gene by Gene, Pathway Genomics, and the University of Washington have said that they will be launching BRCA gene tests.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.